Search Results - "WALTERHOUSE, David O"

Sonic hedgehog regulation of Foxf2 promotes cranial neural crest mesenchyme proliferation and is disrupted in cleft lip morphogenesis by Everson, Joshua L, Fink, Dustin M, Yoon, Joon Won, Leslie, Elizabeth J, Kietzman, Henry W, Ansen-Wilson, Lydia J, Chung, Hannah M, Walterhouse, David O, Marazita, Mary L, Lipinski, Robert J

“…Cleft lip is one of the most common human birth defects, yet our understanding of the mechanisms that regulate lip morphogenesis is limited. Here, we show in…”
Get full text

Results of the Intergroup Rhabdomyosarcoma Study Group D9602 Protocol, Using Vincristine and Dactinomycin With or Without Cyclophosphamide and Radiation Therapy, for Newly Diagnosed Patients With Low-Risk Embryonal Rhabdomyosarcoma: A Report From the Soft Tissue Sarcoma Committee of the Children's Oncology Group by BEVERLY RANEY, R, WALTERHOUSE, David O, MEZA, Jane L, ANDRASSY, Richard J, BRENEMAN, John C, CRIST, William M, MAURER, Harold M, MEYER, William H, PARHAM, David M, ANDERSON, James R

“…Patients with localized, grossly resected, or gross residual (orbital only) embryonal rhabdomyosarcoma (ERMS) had 5-year failure-free survival (FFS) rates of…”
Get full text

Histologic and Clinical Characteristics Can Guide Staging Evaluations for Children and Adolescents With Rhabdomyosarcoma: A Report From the Children's Oncology Group Soft Tissue Sarcoma Committee by WEISS, Aaron R, LYDEN, Elizabeth R, WOMER, Richard B, ANDERSON, James R, HAWKINS, Douglas S, SPUNT, Sheri L, WALTERHOUSE, David O, WOLDEN, Suzanne L, PARHAM, David M, RODEBERG, David A, KAO, Simon C

“…To simplify the recommended staging evaluation by correlating tumor and clinical features with patterns of distant metastasis in newly diagnosed patients with…”
Get full text

Randomized Phase II Window Trial of Two Schedules of Irinotecan With Vincristine in Patients With First Relapse or Progression of Rhabdomyosarcoma: A Report From the Children's Oncology Group by MASCARENHAS, Leo, LYDEN, Elizabeth R, BREITFELD, Philip P, WALTERHOUSE, David O, DONALDSON, Sarah S, PAIDAS, Charles N, PARHAM, David M, ANDERSON, James R, MEYER, William H, HAWKINS, Douglas S

“…To compare response rates for two schedules of irinotecan with vincristine in patients with rhabdomyosarcoma at first relapse or disease progression. Patients…”
Get full text

The significance of margins in pediatric Non‐Rhabdomyosarcoma soft tissue sarcomas: Consensus on surgical margin definition harmonization from the INternational Soft Tissue SaRcoma ConsorTium (INSTRuCT) by Sparber‐Sauer, Monika, Ferrari, Andrea, Spunt, Sheri L., Vokuhl, Christian, Casey, Dana, Lautz, Timothy B., Meyer, William H., Walterhouse, David O., Pajtler, Kristian W., Alaggio, Rita, Schmidt, Andreas, Safwat, Akmal, Timmermann, Beate, Dall'Igna, Patrizia, Chen, Sonja, Weiss, Aaron R., Orbach, Daniel

“…Background Margin status following surgery in children, adolescents, and young adults with soft tissue sarcomas is controversial and has been defined…”
Get full text

Severe labile hypertension in a patient with catecholamine-secreting neuroblastoma: a case report by Frisby-Zedan, Jeanne, Migotsky, Michael, Walterhouse, David O., Verghese, Priya S.

“…Neuroblastoma is a common pediatric tumor arising from the post-ganglionic sympathetic nervous system and is associated with hypertension in 25% of cases. We…”
Get full text

Quantification of Vincristine and its Major Metabolite in Human Plasma by High-Performance Liquid Chromatography/Tandem Mass Spectrometry by Dennison, Jennifer B, Renbarger, Jamie L, Walterhouse, David O, Jones, David R, Hall, Stephen D

“…An analytical method using electrospray ionization and high-performance liquid chromatography/tandem mass spectrometry (LC/ESI-MS/MS) was developed to quantify…”
Get full text

The treatment approach to pediatric non-rhabdomyosarcoma soft tissue sarcomas: a critical review from the INternational Soft Tissue SaRcoma ConsorTium by Ferrari, Andrea, Orbach, Daniel, Sparber-Sauer, Monika, Walterhouse, David O., Pajtler, Kristian W., Meyer, William H., Spunt, Sheri L., Weiss, Aaron R.

“…The current article focuses on non-rhabdomyosarcoma soft tissue sarcoma (NRSTS), the heterogeneous group of mesenchymal tumours different from rhabdomyosarcoma…”
Get full text

Efficacy of Topotecan and Cyclophosphamide Given in a Phase II Window Trial in Children With Newly Diagnosed Metastatic Rhabdomyosarcoma: A Children’s Oncology Group Study by WALTERHOUSE, David O, LYDEN, Elizabeth R, BREITFELD, Philip P, QUALMAN, Stephen J, WHARAM, Moody D, MEYER, William H

“…To determine the antitumor activity and toxicity of topotecan given immediately after cyclophosphamide as window therapy, then in combination with conventional…”
Get full text

Shorter-duration therapy using vincristine, dactinomycin, and lower-dose cyclophosphamide with or without radiotherapy for patients with newly diagnosed low-risk rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group by Walterhouse, David O, Pappo, Alberto S, Meza, Jane L, Breneman, John C, Hayes-Jordan, Andrea A, Parham, David M, Cripe, Timothy P, Anderson, James R, Meyer, William H, Hawkins, Douglas S

“…Intergroup Rhabdomyosarcoma Study Group (IRSG) studies III and IV showed improved failure-free survival (FFS) rates with vincristine, dactinomycin, and…”
Get full text

Reduction of cyclophosphamide dose for patients with subset 2 low‐risk rhabdomyosarcoma is associated with an increased risk of recurrence: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group by Walterhouse, David O., Pappo, Alberto S., Meza, Jane L., Breneman, John C., Hayes‐Jordan, Andrea, Parham, David M., Cripe, Timothy P., Anderson, James R., Meyer, William H., Hawkins, Douglas S.

“…BACKGROUND Failure‐free survival (FFS) and overall survival (OS) rates were found to improve on Intergroup Rhabdomyosarcoma Study (IRS) IV (IRS‐IV) compared…”
Get full text

Survival of Patients With Non‐Rhabdomyosarcoma Soft Tissue Sarcomas of the Head and Neck by Rastatter, Jeffrey C., Sinard, Rebecca N., Dilger, Amanda, Reichek, Jennifer, Walterhouse, David O., Patel, Urjeet

“…Objective To evaluate factors associated with overall survival (OS) of patients with non‐rhabdomyosarcoma soft tissue sarcomas of the head and neck. Study…”
Get full text

Patients with completely resected nongenitourinary low‐risk embryonal rhabdomyosarcoma are candidates for reduced duration low‐intensity chemotherapy by Bisogno, Gianni, Fuchs, Joerg, Dasgupta, Roshni, Ferrari, Andrea, Haduong, Josephine H., Rogers, Timothy, Walterhouse, David O., Coppadoro, Beatrice, Xue, Wei, Vokuhl, Christian, Hawkins, Douglas S., Seitz, Guido, Merks, Johannes H. M., Sparber‐Sauer, Monika, Venkatramani, Rajkumar

“…Background The survival of patients with localized embryonal rhabdomyosarcoma (RMS) completely resected at diagnosis is greater than 90%. Most patients have…”
Get full text

Suboptimal outcome for patients with biliary rhabdomyosarcoma treated on low‐risk clinical trials: A report from the Children's Oncology Group by Aye, Jamie M., Xue, Wei, Palmer, Joshua D., Walterhouse, David O., Arnold, Michael A., Heaton, Todd E., Venkatramani, Rajkumar

“…Background Biliary rhabdomyosarcoma (RMS) is the most common biliary tumor in children. The biliary tract is classified as a favorable primary site. Therefore,…”
Get full text

Impact of local control and surgical lymph node evaluation in localized paratesticular rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee by Routh, Jonathan C., Dasgupta, Roshni, Chi, Yueh‐Yun, Shnorhavorian, Margarett, Tian, Jing, Walterhouse, David O., Breneman, John, Wolden, Suzanne L., Arndt, Carola A., Hawkins, Douglas S., Rodeberg, David A.

“…Paratesticular rhabdomyosarcoma (PT‐RMS) carries a favorable prognosis, but questions persist regarding optimal management. Our goal was to determine the…”
Get full text

Cardiac-Sparing Whole Lung IMRT in Patients With Pediatric Tumors and Lung Metastasis: Final Report of a Prospective Multicenter Clinical Trial by Kalapurakal, John A., Gopalakrishnan, Mahesh, Walterhouse, David O., Rigsby, Cynthia K., Rademaker, Alfred, Helenowski, Irene, Kessel, Sandy, Morano, Karen, Laurie, Fran, Ulin, Ken, Esiashvili, Natia, Katzenstein, Howard, Marcus, Karen, Followill, David S., Wolden, Suzanne L., Mahajan, Anita, Fitzgerald, Thomas J.

“…A prospective clinical trial was conducted for patients undergoing cardiac sparing (CS) whole lung irradiation (WLI) using intensity modulated radiation…”
Get full text

Risk‐based treatment for patients with first relapse or progression of rhabdomyosarcoma: A report from the Children's Oncology Group by Mascarenhas, Leo, Lyden, Elizabeth R., Breitfeld, Philip P., Walterhouse, David O., Donaldson, Sarah S., Rodeberg, David A., Parham, David M., Anderson, James R., Meyer, William H., Hawkins, Douglas S.

“…Background The purpose of this study was to evaluate risk and response–based multi‐agent therapy for patients with rhabdomyosarcoma (RMS) at first relapse…”
Get full text

Emerging Roles for Hedgehog-Patched-Gli Signal Transduction in Reproduction by Walterhouse, David O, Lamm, Marilyn L G, Villavicencio, Elisabeth, Iannaccone, Philip M

“…Hedgehog (Hh) proteins are expressed during vertebrate development in some tissues with inductive properties and at epithelial-mesenchymal boundaries in…”
Get full text

Clinical group and modified TNM stage for rhabdomyosarcoma: A review from the Children's Oncology Group by Crane, Jacquelyn N., Xue, Wei, Qumseya, Amira, Gao, Zhengya, Arndt, Carola A. S., Donaldson, Sarah S., Harrison, Douglas J., Hawkins, Douglas S., Linardic, Corinne M., Mascarenhas, Leo, Meyer, William H., Rodeberg, David A., Rudzinski, Erin R., Shulkin, Barry L., Walterhouse, David O., Venkatramani, Rajkumar, Weiss, Aaron R.

“…The Children's Oncology Group (COG) uses Clinical Group (CG) and modified Tumor Node Metastasis (TNM) stage to classify rhabdomyosarcoma (RMS). CG is based on…”
Get full text

Serologic response and clinical efficacy of influenza vaccination in children and young adults on chemotherapy for cancer by Choi, Daniel K., Fuleihan, Ramsay L., Walterhouse, David O.

“…Background Influenza is a health risk to children receiving chemotherapy for cancer. An absolute lymphocyte count (ALC) >1,000 cells/mm3 has been associated…”
Get full text